welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Celecoxib, DFMO combination improved adenoma burden in patients with familial adenomatous polyposis
In a randomized clinical chemoprevention trial, a combination of celecoxib and diflouromethylornithine resulted in a nonsignificant benefit among patients with familial adenomatous polyposis when adenoma count in a defined area was used as the primary endpoint. However, the combination was well tolerated, and a secondary measure of adenoma burden using a video-based global assessment showed a significant incremental benefit.
expertly curated content related to this topic
-
Coping and relaxation techniques with medical procedureshttps://www.youtube.com/watch?v=_tUhIYzA...
-
Selective COX-2 Inhibition Affects Fatty Acids, but not COX mRNA Expression in Patients with FAPFamilial adenomatous polyposis (FAP) pro...
-
What Foods Are OK to Eat After J-pouch Surgery?The j-pouch procedure (for which the te...
-
Prospective Randomized Study of Sulindac versus Calcium and Calciferol for Upper Gastrointestinal Polyps in Familial...Eighteen patients with familial adenomat...
-
Desmoid Tumors: Clinical Features and Treatment Options for Advanced DiseaseDesmoid tumors describe a rare monoclona...
-
Albert de la Chapelle, MD, PhDResearch in Dr. de la Chapelle’s labor...
-
mahipal suraneniTranslational Oncology Lead at PfIzer...